Henry Schein announces antibody rapid blood test
The S&P 500 has returned to session highs with a current 4.2% gain. Shares of Henry Schein (HSIC 54.94, +9.9%) have climbed 10% after the health care company announced the availability of an antibody rapid blood test that delivers results within 15 minutes from a pinprick with no instrumentation required. The test helps health care professionals make more informed decisions about COVID-19 treatments. Separately, House Speaker Pelosi (D-CA) confirmed prior reports that the House may not get the unanimous consent it needs to immediately pass the stimulus bill. She is very confident, as is the market, that the bill will pass with a strong majority, though.